Notably, GSH pre‐injections combined with GSH pulse therapy and anti‐PD‐1 blockade showed the best antitumor activity among all groups, which indicated that improvement of the tumor stromal and immunosuppressive microenvironment significantly enhanced the antitumor activities of γ NPs and anti‐PD‐1. This evidence concerns the gene PDCD1 and neoplasm.